A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation
Status:
Completed
Trial end date:
2015-10-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate dose-responses of efficacy and safety of
ASP0456 in patients with chronic constipation (diagnosed by Rome III criteria of functional
constipation (FC), not including constipation due to organic diseases) compared to placebo
and to find the appropriate dose for P3 study.